Alzheimer's and Parkinson's Diseases: Recent Developments

ISBN-13: 9781475791471 / Angielski / Miękka / 2013 / 724 str.

Israel Hanin; Mitsuo Yoshida;Abraham Fisher

Opis

This book represents the third in a series of International Conferences related to Alzheimer's (AD) and Parkinson's (PD) diseases. The first one took place in Eilat, Israel, in 1985; and the second one in Kyoto, Japan, in 1989. This book contains the full text of oral and poster presentations from the Third International Conference on Alzheimer's and Parkinson's Diseases: Recent Developments, held in Chicago, Illinois, U.S.A. on November 1-6, 1993. The Chicago Conference was attended by 270 participants. The Scientific Program was divided into nine oral sessions, a keynote presentation, and a poster session. The conference culminated in a Round Table Discussion involving all of the participants in the conference. The four and one-half day meeting served as an excellent medium for surveying the current status of clinical and preclinical developments in AD and PD. There were 59 oral presentations and 93 posters. This book incorporates a majority of both.

Spis treści

ClinicalGeneral and Overlap between Alzheimer's Disease and Parkinson's Disease: Visual Processing in Alzheimer's Disease; G.G. Celesia, et al. Betaamyloid Precursor Protein, Tau, and Mechanism of Cell Death: Modulation of APP Processing Neurotransmission; R.M. Nitsch, et al. Etiology, Epidemiology and Potential Risk Factors: Risk Factors of Senile Dementias: Comparisons of Alzheimer's Disease and Vascular Dementias; K. Kondo; et al. Receptor Dynamics, Neurochemistry and Molecular Biology: Localization and Density of Transferrin Binding Sites in the Nigrostriatal System of Control Subjects and Patients with Parkinson's Disease; B.A. Faucheux, et al. Animal Models, Biological and Early Markers: Combined Nicotinic and Muscarinic Cholinergic and Serotonergic Blockade Selectively Impair Acquisition of Spatial Navigation; M. Riekkinen, P. Riekinnen, Jr. Endogenous Toxins: Metabolic Bioactivation of Endogenous Isoquinolines as Dopaminergic Neurotoxins to Elicit Parkinson's Disease; M. Naoi, et al. Treatment and Clinical Trials: Alzheimer's Disease: Neurotransmitter Deficits: Can They Be Corrected; E. Giacobini. Molecular Biology and Genetics. 84 additional articles. Index.